Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Cheng Insider Profile
11 Followers
Andrew Cheng, Director at Arbutus Biopharma, holds ― shares in Arbutus Biopharma (Ticker: ABUS), holds 696.06K shares in Akero Therapeutics (Ticker: AKRO), holds 17.49K shares in Vera Therapeutics (Ticker: VERA). Most recently, Andrew Cheng ― shares of Arbutus Biopharma on ― for an estimated value of ―.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-23.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Cheng holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Cheng
Andrew Cheng's Trading History
Arbutus Biopharma
―
Director
―
―
Akero Therapeutics
Dec 18, 2024
President & CEO, Director
Uninformative Buy
―
$20.42M
Vera Therapeutics
May 18, 2021
Director
Uninformative Buy
―
$744.99K
List of latest transactions for each holding click on a transaction to see Andrew Cheng's performance on stock
You May Also Like
Andrew Cheng insider profile FAQ
What is the percentage of profitable transactions made by Andrew Cheng?
The percentage of profitable transactions made by Andrew Cheng is 0%.
What is the average return per transaction made by Andrew Cheng?
The average return per transaction made by Andrew Cheng is -23.50%.
What stocks does Andrew Cheng hold?
Andrew Cheng holds: ABUS, AKRO, VERA stocks.
What was Andrew Cheng’s latest transaction?
Andrew Cheng latest transaction was an Uninformative Buy of ―.
What was Andrew Cheng's most profitable transaction?
Andrew Cheng’s most profitable transaction was an Informative Sell of AKRO stock on March 15, 2024. The return on the trade was -12.90%.
What is Andrew Cheng's role in Arbutus Biopharma?
Andrew Cheng's role in Arbutus Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.